Phytochemical Screening of Balinese Traditional Herbal as Anticancer Candidates Using GC-MS and Molecular Docking Analysis
DOI:
https://doi.org/10.70062/globalhealth.v2i2.201Keywords:
Bioactive, Cancer, Suruhan, Tapak liman, Temu irengAbstract
Indonesia's biodiversity holds great potential for drug development, including through the use of traditional medicinal plants such as tapak liman (Elephantopus scaber L.), suruhan (Peperomia pellucida L. Kunth), and temu ireng (Curcuma aeruginosa Roxb.). These plants have been used in traditional medicine and are known to contain bioactive compounds with potential anticancer properties. Tapak liman contains compounds capable of inducing apoptosis in cancer cells. Suruhan is known to have cytotoxic and immunomodulatory effects, while temu ireng contains compounds with antioxidant and anticancer activity. This study aims to identify and quantify the bioactive compounds in these three plants using Gas Chromatography-Mass Spectrometry (GC-MS) and to explore their therapeutic potential in cancer treatment. The results of GC-MS analysis successfully identified six main compounds that have potential as anticancer agents, namely Phytol, Caryophyllene, Apiol, Germacrone, Germacrene B, and one additional compound. Temu ireng contains Germacrone, Germacrene B, and Caryophyllene, while suruhan contains Caryophyllene, Apiol, and Phytol. Meanwhile, tapak liman shows the presence of bioactive compounds that support cytotoxic activity. The focus of this study is on the interaction of bioactive compounds with the Bcl-2 protein, which plays a role in inhibiting apoptosis in cancer cells. Additionally, molecular analysis revealed that Germacrone, Germacrene B, Caryophyllene, and Apiol can also bind to the p53 protein, known as a guardian of the genome and a trigger for apoptosis. These findings suggest that the three plants have high potential as natural sources of anticancer agents. Further in vitro and in vivo studies are recommended to test the biological efficacy of these compounds in the context of cancer therapy, thereby bridging traditional knowledge with modern scientific approaches in the development of natural-based medications.
References
Singh, S. R., Bhaskar, R., Ghosh, S., Yarlagadda, B., Singh, K. K., Verma, P., Sengupta, S., Mladenov, M., Hadzi-Petrushev, N., Stojchevski, R., Sinha, J. K., and Avtanski, D., “Exploring the Genetic Orchestra of Cancer: The Interplay Between Oncogenes and Tumor-Suppressor Genes,” Cancers, vol. 17, no. 7, p. 1082, 2025. [Online]. Available: https://doi.org/10.3390/cancers17071082
Castaneda, M., den Hollander, P., Kuburich, N. A., Rosen, J. M., and Mani, S. A., “Mechanisms of cancer metastasis,” Seminars in Cancer Biology, vol. 87, pp. 17–31, 2022. [Online]. Available: https://doi.org/10.1016/j.semcancer.2022.10.006
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., and Jemal, A., “Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries,” CA Cancer J Clin., vol. 74, no. 3, pp. 229–263, May–Jun. 2024. [Online]. Available: https://doi.org/10.3322/caac.21834
Roy, A., Khan, A., Ahmad, I., Alghamdi, S., Rajab, B. S., Babalghith, A. O., Alshahrani, M. Y., Islam, S., and Islam, M. R., “Flavonoids a Bioactive Compound from Medicinal Plants and Its Therapeutic Applications,” Biomed Res Int., vol. 2022, p. 5445291, Jun. 2022. [Online]. Available: https://doi.org/10.1155/2022/5445291
Yan, Q., Xing, Q., Liu, Z., Zou, Y., Liu, X., and Xia, H., “The phytochemical and pharmacological profile of dandelion,” Biomedicine & Pharmacotherapy, vol. 179, p. 117334, 2024. [Online]. Available: https://doi.org/10.1016/j.biopha.2024.117334
Ullah, A., Munir, S., Badshah, S. L., Khan, N., Ghani, L., Poulson, B. G., Emwas, A. H., and Jaremko, M., “Important Flavonoids and Their Role as a Therapeutic Agent,” Molecules, vol. 25, no. 22, p. 5243, Nov. 2020. [Online]. Available: https://doi.org/10.3390/molecules25225243
Alghoull, A. E., Firdausi, S. R., Christina, Y. I., Widyarti, S., Rifa'i, M., and Djati, M. S., “Evaluating the efficacy of ethanolic extract of Tapak Liman (Elephantopus scaber L.) leaf in inhibiting pulmonary fibrosis: Mechanisms through anti-fibrotic cytokine promotion,” Open Vet J., vol. 15, no. 1, pp. 118–125, Jan. 2025. [Online]. Available: https://doi.org/10.5455/OVJ.2025.v15.i1.11
Ahmad, I., Hikmawan, B., Sulistiarini, R., and Mun'im, A., “Peperomia pellucida (L.) Kunth herbs: A comprehensive review on phytochemical, pharmacological, extraction engineering development, and economic promising perspectives,” Journal of Applied Pharmaceutical Science, 2023. [Online]. Available: https://doi.org/10.7324/JAPS.2023.130201
Lee, J.-E., Jayakody, T. M. J., Kim, J.-I., Jeong, J.-W., Choi, K.-M., Kim, T.-S., Seo, C., Azimi, I., Hyun, J., and Ryu, B., “The Influence of Solvent Choice on the Extraction of Bioactive Compounds from Asteraceae: A Comparative Review,” Foods, vol. 13, no. 19, p. 3151, 2024. [Online]. Available: https://doi.org/10.3390/foods13193151
Wu, L., Wang, L., Tian, X., Zhang, J., and Feng, H., “Germacrone exerts anti-cancer effects on gastric cancer through induction of cell cycle arrest and promotion of apoptosis,” BMC Complement Med Ther., vol. 20, no. 1, p. 21, Jan. 2020. [Online]. Available: https://doi.org/10.1186/s12906-019-2810-3
Quintans, J. S., Soares, B. M., Ferraz, R. P., Oliveira, A. C., da Silva, T. B., Menezes, L. R., Sampaio, M. F., Prata, A. P., Moraes, M. O., Pessoa, C., Antoniolli, A. R., Costa, E. V., and Bezerra, D. P., “Chemical constituents and anticancer effects of the essential oil from leaves of Xylopia laevigata,” Planta Med., vol. 79, no. 2, pp. 123–130, Jan. 2013. [Online]. Available: https://doi.org/10.1055/s-0032-1328091
Lei, J., Wang, Q., Li, G., Li, Y., Zhang, P., and Xu, G., “β-Caryophyllene from Chilli Pepper Inhibits the Proliferation of Non-Small Cell Lung Cancer Cells by Affecting miR-659-3p-Targeted Sphingosine Kinase 1 (SphK1),” Int J Gen Med., vol. 14, pp. 9599–9613, 2021. [Online]. Available: https://doi.org/10.2147/IJGM.S338513
Wu, K. H., Lee, W. J., Cheng, T. C., Chang, H. W., Chen, L. C., Chen, C. C., Lien, H. M., Lin, T. N., and Ho, Y. S., “Study of the antitumor mechanisms of apiole derivatives (AP-02) from Petroselinum crispum through induction of G0/G1 phase cell cycle arrest in human COLO 205 cancer cells,” BMC Complement Altern Med., vol. 19, no. 1, p. 188, Jul. 2019. [Online]. Available: https://doi.org/10.1186/s12906-019-2590-9
Wu KH, Lee WJ, Cheng TC, Chang HW, Chen LC, Chen CC, Lien HM, Lin TN, and Ho YS, “Study of the antitumor mechanisms of apiole derivatives (AP-02) from Petroselinum crispum through induction of G0/G1 phase cell cycle arrest in human COLO 205 cancer cells,” BMC Complement. Altern. Med., vol. 19, no. 1, p. 188, Jul. 2019, https://doi.org/10.1186/s12906-019-2590-9.
Yu J, Jin F, Tang Y, and Huang Y, “In vitro anticancer activity of phytol on human non-small cell lung cancer A549 cells,” Integr. Cancer Ther., vol. 24, 2025, https://doi.org/10.1177/15347354251344592.
Qian S, Wei Z, Yang W, Huang J, Yang Y, and Wang J, “The role of BCL-2 family proteins in regulating apoptosis and cancer therapy,” Front. Oncol., vol. 12, p. 985363, Oct. 2022, https://doi.org/10.3389/fonc.2022.985363.
Wang H, Guo M, Wei H, et al., “Targeting p53 pathways: mechanisms, structures and advances in therapy,” Signal Transduct. Target. Ther., vol. 8, p. 92, 2023, https://doi.org/10.1038/s41392-023-01347-1.
Gowtham HG, Ahmed F, Anandan S, et al., “In silico computational studies of bioactive secondary metabolites from Wedelia trilobata against anti-apoptotic B-cell lymphoma-2 (Bcl-2) protein associated with cancer cell survival and resistance,” Molecules, vol. 28, no. 4, p. 1588, Feb. 2023, https://doi.org/10.3390/molecules28041588.
Laptenko O, and Prives C, “p53: master of life, death, and the epigenome,” Genes Dev., vol. 31, pp. 955–956, 2017, https://doi.org/10.1101/gad.302364.117.
Labuschagne CF, Zani F, and Vousden KH, “Control of metabolism by p53-cancer and beyond,” Biochim. Biophys. Acta Rev. Cancer, vol. 1870, pp. 32–42, 2018, https://doi.org/10.1016/j.bbcan.2018.06.001.
Kaiser AM, and Attardi LD, “Deconstructing networks of p53-mediated tumor suppression in vivo,” Cell Death Differ., vol. 25, pp. 93–103, 2018, https://doi.org/10.1038/cdd.2017.171.
Mello SS, and Attardi LD, “Deciphering p53 signaling in tumor suppression,” Curr. Opin. Cell Biol., vol. 51, pp. 65–72, 2018, https://doi.org/10.1016/j.ceb.2017.11.005.
Wu L, Wang L, Tian X, Zhang J, and Feng H, “Germacrone exerts anti-cancer effects on gastric cancer through induction of cell cycle arrest and promotion of apoptosis,” BMC Complement. Med. Ther., vol. 20, no. 1, p. 21, Jan. 2020, https://doi.org/10.1186/s12906-019-2810-3.
Panyajai P, Viriyaadhammaa N, Tima S, et al., “Anticancer activity of Curcuma aeruginosa essential oil and its nano-formulations: Cytotoxicity, apoptosis and cell migration effects,” BMC Complement. Med. Ther., vol. 24, p. 16, 2024, https://doi.org/10.1186/s12906-023-04261-9.
Rafi M, Azka RR, and Nurhasanah D, “Efektivitas nanoemulsi ekstrak Curcuma aeruginosa terhadap sel kanker payudara (MCF-7): Studi sitotoksik dan kinetika waktu,” J. Teknol. Farm. Indones., vol. 12, no. 1, pp. 30–38, 2021.
Tran KL, Lam NTA, and Ngo QMT, “Cytotoxic activity of fractions and compounds from Peperomia pellucida,” Vietnam Med. J., pp. 119–121, 2024, https://doi.org/10.51298/vmj.v538i1.9541.
Lydia E, Hidayat T, and Purnomo H, “Potensi antikanker senyawa aktif dari Peperomia pellucida terhadap sel MCF-7 dan A549,” J. Fitofarmaka Indones., vol. 12, no. 2, pp. 135–142, 2021.
Gong RH, Chen JW, Shen LS, et al., “Assessing the therapeutic potential of Elephantopus scaber extract in hepatocellular carcinoma by inhibiting the PI3K/Akt pathway,” J. Funct. Foods, vol. 113, p. 106009, 2024, https://doi.org/10.1016/j.jff.2024.106009.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Global Health: Journal of Health Sciences, Public Health and Pharmacy
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
